ASTA Comments on FDA Request for Information on Gluten Labeling and Cross-Contact in Packaged Foods
In April 2026, ASTA submitted comments in response to the Food and Drug Administration's (FDA) request for information (RFI) on labeling and cross-contact of gluten in packaged foods, which specifically referenced ingredients that can be declared using collective terms, such as spices. ASTA's comments highlight that no spices inherently contain gluten, note that FDA should take a scientific, risk-based approach to unintended gluten presence, and express support for consistency with existing FDA requirements and harmonization with internal standards for gluten labeling.
04/16/2026 at 12:00 am
1
Related Resources
ASTA Letter to Chairman Dingell on Proposed Food Safety Legislation
ASTA sent a letter to to Chairman Dingell of the U.S. House of Representatives expressing support for ensuring the safety of the nation's food supply through a well-funded FDA while opposing certain provisions, including those of proposed taxes on food facilities and importers, facility certification requirements for all food imports, and new regulatory requirements such as labeling mandates and civil penalties.
Multi-Industry Comments on the Voluntary Disclosure of Sesame as an Allergen
ASTA signed onto industry coalition comments to the Food and Drug Administration (FDA) in February 2021 regarding the FDA's draft guidance titled Voluntary Disclosure of Sesame as an Allergen.
